Literature DB >> 31186861

Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers.

Mazen Noureddin1, Rohit Loomba1,2.   

Abstract

Entities:  

Year:  2012        PMID： 31186861      PMCID： PMC6499277          DOI： 10.1002/cld.65

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  15 in total

Review 1.  AGA technical review on nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Authors:  Vlad Ratziu; Stefano Bellentani; Helena Cortez-Pinto; Chris Day; Giulio Marchesini
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

3.  Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.

Authors:  Brent A Neuschwander-Tetri; Jeanne M Clark; Nathan M Bass; Mark L Van Natta; Aynur Unalp-Arida; James Tonascia; Claudia O Zein; Elizabeth M Brunt; David E Kleiner; Arthur J McCullough; Arun J Sanyal; Anna Mae Diehl; Joel E Lavine; Naga Chalasani; Kris V Kowdley
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

4.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

5.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Authors:  Christopher D Williams; Joel Stengel; Michael I Asike; Dawn M Torres; Janet Shaw; Maricela Contreras; Cristy L Landt; Stephen A Harrison
Journal:  Gastroenterology       Date:  2010-09-19       Impact factor: 22.682

6.  Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.

Authors:  Nicole A Palekar; Rhonda Naus; Steven P Larson; John Ward; Stephen A Harrison
Journal:  Liver Int       Date:  2006-03       Impact factor: 5.828

Review 7.  Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

Authors:  Brent A Neuschwander-Tetri; Stephen H Caldwell
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

8.  Long-term follow-up of patients with nonalcoholic fatty liver.

Authors:  Nila Rafiq; Chunhong Bai; Yun Fang; Manirath Srishord; Arthur McCullough; Terry Gramlich; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2008-11-07       Impact factor: 11.382

9.  The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

Authors:  Paul Angulo; Jason M Hui; Giulio Marchesini; Ellisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James Kench; Terry M Therneau; Christopher P Day
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

10.  A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Authors:  Zobair M Younossi; Mohammed Jarrar; Clare Nugent; Manpreet Randhawa; Mariam Afendy; Maria Stepanova; Nila Rafiq; Zachary Goodman; Vikas Chandhoke; Ancha Baranova
Journal:  Obes Surg       Date:  2008-05-24       Impact factor: 4.129
View more
  9 in total

1.  Objective Liver Fibrosis Estimation from Shear Wave Elastography.

Authors:  Laura J Brattain; Brian A Telfer; Manish Dhyani; Joseph R Grajo; Anthony E Samir
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2018-07

2.  Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease.

Authors:  An Tang; Ajinkya Desai; Gavin Hamilton; Tanya Wolfson; Anthony Gamst; Jessica Lam; Lisa Clark; Jonathan Hooker; Tanya Chavez; Brandon D Ang; Michael S Middleton; Michael Peterson; Rohit Loomba; Claude B Sirlin
Journal:  Radiology       Date:  2014-09-22       Impact factor: 11.105

3.  Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population.

Authors:  Dariusz Narankiewicz; Josefina Ruiz-Nava; Veronica Buonaiuto; María Isabel Ruiz-Moreno; María Dolores López-Carmona; Luis Miguel Pérez-Belmonte; Ricardo Gómez-Huelgas; María Rosa Bernal-López
Journal:  Int J Environ Res Public Health       Date:  2020-05-18       Impact factor: 3.390

4.  Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis.

Authors:  Alexa M Giammarino; He Qiu; Kishen Bulsara; Sabrina Khan; Yu Jiang; Ben L Da; David E Bernstein; Sanjaya K Satapathy
Journal:  Hepatol Commun       Date:  2021-10-20

5.  Clitorin ameliorates western diet-induced hepatic steatosis by regulating lipogenesis and fatty acid oxidation in vivo and in vitro.

Authors:  Divina C Cominguez; Yea-Jin Park; Yun-Mi Kang; Agung Nugroho; Suhyun Kim; Hyo-Jin An
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

6.  Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol.

Authors:  Xiaoyu Wang; Yong Han; Yufei Liu; Haofei Hu
Journal:  BMC Gastroenterol       Date:  2022-09-14       Impact factor: 2.847

Review 7.  Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications.

Authors:  Duanghathai Pasanta; Khin Thandar Htun; Jie Pan; Montree Tungjai; Siriprapa Kaewjaeng; Hongjoo Kim; Jakrapong Kaewkhao; Suchart Kothan
Journal:  Diagnostics (Basel)       Date:  2021-05-07

8.  Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia.

Authors:  Igor V Maev; Aleksey A Samsonov; Liudmila K Palgova; Chavdar S Pavlov; Elena N Shirokova; Elena I Vovk; Kirill M Starostin
Journal:  BMJ Open Gastroenterol       Date:  2020-03-26

9.  A Model Incorporating Serum Alkaline Phosphatase for Prediction of Liver Fibrosis in Adults with Obesity and Nonalcoholic Fatty Liver Disease.

Authors:  Ahmad Hassan Ali; Gregory F Petroski; Alberto A Diaz-Arias; Alhareth Al Juboori; Andrew A Wheeler; Rama R Ganga; James B Pitt; Nicole M Spencer; Ghassan M Hammoud; R Scott Rector; Elizabeth J Parks; Jamal A Ibdah
Journal:  J Clin Med       Date:  2021-07-27       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.